FDA Drug Application (016990) for INTAL by SANOFI AVENTIS US

Back to FDA Applications sponsored by SANOFI AVENTIS US

Application Number016990
Product Number001
FormCAPSULE;INHALATION
Dosage20MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameINTAL
Active IngredientCROMOLYN SODIUM



Back to FDA Applications sponsored by SANOFI AVENTIS US

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.